Dialysis Market Size, Share & Industry Analysis, By Type (Products and Services), By Dialysis Type (Hemodialysis and Peritoneal Dialysis), By End User (Dialysis Centers & Hospitals and Home Care), and Regional Forecast, 2020-2027

The global dialysis market size was USD 90.33 billion in 2019 and is projected to reach USD 177.56 billion by 2027, exhibiting a CAGR of 7.7% during the forecast period.

Dialysis market growth is driven by significant rise in the prevalence of chronic kidney diseases, which in turn has increased  patient visits in renal therapy  clinics over the last decade. Moreover, improved reimbursement policies for renal therapy by private as well as public institutions is boosting the expansion of the market at a remarkable rate. For instance, according to the End-Stage Renal Disease (ESRD) PPS final rule, Centers for Medicare & Medicaid Services (CMS) expects to pay around US$ 10.3 billion in Medicare reimbursements to approximately 7,000 ESRD providers in 2020 for the costs of delivering renal hemodialysis services.

Moreover, the market is projected to witness a boost in growth owing to the recent COVID-19 outbreak. The increasing number of patients affected by COVID-19 has  led  to a rise in the demand for renal equipment, as critically ill patients are experiencing  multiple organ failure, including kidney failure. As per National Institutes of Health (NIH), around 5% of the COVID-19 patients are currently experiencing acute kidney injury and would require renal replacement therapy. This scenario has led to an increase in the adoption of renal therapy equipment in hospital settings and is projected to propel the market in coming years.

LATEST TRENDS

Request a Free sample to learn more about this report.

Shift Of Patients From Clinics To Homecase Settings Identified As A Significant Market Trend

Patients with end-stage renal disease (ESRD) are required to undergo treatment at renal facilities or they can opt for these services at home. Rising preference of patients for receiving care at home, especially in the developed economies, is one of the key trends in the market. Also, governments in nations such as the U.S. are engaged in setting up new payment methods for treating kidney disease, which can favor lower cost care at home. This is estimated to propel the number of patients opting for treatment in home care settings in coming years.

Emergence of Advanced Renal Care Machines to Augment the Market Growth

Key companies such as B.Braun and Fresenius Kabi are engaged in developing and introducing technologically efficient advancements and advanced dialyzers in the global market to gain strategically advantageous position. The companies are focusing more on the potential regions to improve the accessibility of patient population towards care delivery. For instance, Fresenius Kabi, one of the major players in the market, launched 4008A machine in January 2019, which is specially designed to meet the requirements of populations in emerging markets.

DRIVING FACTORS

 Rising  Prevalence of Chronic Kidney Diseases to Augment the Market

The overall burden of ESRD and CKD is one of the highest in terms of cost and healthcare services. Rising incidence of chronic kidney diseases and renal failure is one of the key factors for the growth of this market. ESRD is the stage when one or both the kidneys permanently stop working properly, and the patient needs to undergo long-term renal infusion therapy or receive a kidney transplant. Thus, rising prevalence of ESRD is augmenting the cost burden of kidney diseases in the world and is one of the key factors for the increasing revenue generataion from the services. According to the CDC, around 15% of the U.S. population and 14% of Hispanics are suffering from CKD.

Combined with this is the outbreak of COVID-19 pandemic, which is estimated to further aid the growth of the market for next few years. This is predominantly attributed to the active guidelines issued by government bodies to undertake the procedure in critical COVID-19 patients. For instance, recently the Government of India has issued guidlenes regarding the dialysis procedures for COVID-19 patients such as, state should earmark and identify one facility with adequate proportion of trained staff, dialysis machines, water treatment systems and other support equipments as preliminary measures, in case of increase in Covid-19 pandemic.

Further, the green signal by regulatory authorities for the introduction of new products and consumables, participation of public authorities to prevent and control renal diseases, and collaborative work done by various organizations to give such efficient renal services in the niche areas of developing regions are estimated to boost the market growth.

Improved Accessibility To Hemodialysis Care Centers to Drive Market Growth

The prevalence of CKD has increased remarkably, which is propelling the demand for efficient renal facilities with lesser waiting time. The availability of well-qualified nephrologists in developed countries has in turn increased the count of renal care facilities. Moreover, to cater to the rising demand for renal care in emerging economies,  investors are focusing more on increasing  renal treatment centers in countries such as India, China, Mexico, etc. This is expected to fuel the revenue generated in the market in the coming years. The affordable care delivery in such countries is expanding the number of visits in these facilities.

RESTRAINING FACTORS

Rising Patient Pool Opting For Kidney Transplantation Procedure To Restrict the Market Growth

Kidney transplantation is one of the alternate treatment options for patients suffering from ESRD and stage III CKD, wherein the patients receive kidney from their donor and the affected kidney is replaced by a healthy one. The better treatment outcomes associated with kidney transplant and affordability of the procedure owing to the favorable reimbursement policies is projected to affect the growth of the market during the forecast period. Patients diagnosed with ESRD prefer kidney transplantation over renal infusion owing to the long-term benefits associated with the procedure. Combined with this, published articles and journals have also reported that there has been an increase in the cost of renal therapy owing to the coronavirus pandemic in India. This could negatively affect the market growth.

SEGMENTATION

By Type Analysis

To know how our report can help streamline your business, Speak to Analyst

Dialysis Services to Gain Momentum during the Forecast Period

Based on type, the market is segmented into products and services. Services accounted for the maximum share in 2019,  mainly due to the emergence of well-equipped renal care facilities for chronic and acute care across the globe and rising focus on quality-care delivery to the patients by service providers. Moreover, improved business models by the service providers, which are patient-centric and profit driven, are augmenting the demand for services.  Products segment is expected to witness healthy growth in coming years owing to rise the number of local & regional players in this market to cater to the rising demand for advanced products and consumables. 

By Dialysis Type Analysis

Hemodialysis to Account for  Maximum Share

By type, the global market is categorized into hemodialysis and peritoneal dialysis. Hemodialysis generated highest revenue amongst the two in 2019 and is expected to remain dominant in terms of revenue throughout the forecast period. Inadequate training provided for peritoneal treatment in developed as well as developing countries has reduced the preference for peritoneal. Moreover, the clinical benefits associated with this procedure such as lesser time required for the procedure and adoption of arteriovenous fistula (AV Fistula) is propelling the demand for hemodialysis. 

By End User Analysis

Dialysis Centers and Hospitals to Retain Their Leading Position

Various end users in the global market are segmented into centers & hospitals, and home care. In terms of value, dialysis treatments centers accounted for the leading market share in 2019, which is attributable to the favorable reimbursement provided by renal facilities and hospitals for  renal therapies, rising patient pool suffering from CKD and ESRD, and rising healthcare expenditure by  the population. However, homecare is anticipated to be the fastest-growing segment during the forecast period at a considerably higher CAGR. Increasing number of COVID-19 is estimated to augment the growth of the hospitals segment in the immediate future. As of May 2020, there are an estimated 1.68 million confirmed cases of coronavirus in the U.S. and close to 5 million cases worldwide.

REGIONAL INSIGHTS

To get more information on the regional analysis of this market, Request a Free sample

The market size in North America stood at USD 36.46 billion in 2019. Through the findings based on our research methodology, North America is projected to dominate the market share during the forecast period. High prevalence of CKD and ESRD in the U.S. and Canada, coupled with higher treatment rates in these countries, are the key factors estimated to boost the expansion of the market during the forecast period. The U.S is also projected to witness  growth in the demand for the services and product, attributable  to the increasing incidence of coronavirus infections and subsequent renal failures. Europe is expected to emerge as the second-largest region in this market in terms of size, witnessing moderate growth in long-term period. High growth is majorly due to increasing rate of geriatric population suffering from renal disorders in the region. Moreover, as per our market research study, Asia-Pacific is expected to witness relatively significant growth in terms of value in this  market. Funding by public players to improve the accessibility of renal care is likely to augment the expansion of the market during the forecast period. In December 2016, the National Health and Family Planning Commission of China set up the regulations for the basic standard and the management of hemodialysis centers, with an aim to standardize the development of independent such centers in the country. Such established regulatory scenario for renal treatment  facilities is projected to boost the expansion of the market in Asia-Pacific during the forecast period.

In Brazil,  rising incidence of CKD among the elderly population is boosting the growth of the market for services and products. The Middle East & Africa region is estimated to reflect slow-to-moderate growth during the forecast period, attributable to the delayed diagnosis of chronic CKD and ESRD. However, rapid urbanization in the region and growing awareness about the severity of renal diseases are the key factors estimated to propel the revenue from this region  during the forecast period.

KEY INDUSTRY PLAYERS

Diligent Efforts by Companies such as Fresenius Medical to Introduce Novel Products will Strengthen Market Position

Fresenius Medical Care and Baxter International accounted for the maximum market share in 2019, owing to their strong network of renal care facilities. Fresenius Kidney Care, which is a division of Fresenius Medical Care North America, provides renal care and support services to over 190,000 people with kidney disease annually at more than 2,400 renal care facilities nationwide. Moreover, US FDA approval for novel renal care devices of Fresenius is propelling its market share. For instance, in October 2019, the USFDA granted breakthrough device designation to its new hemodialysis system currently in development, designed to prevent blood clotting without the use of blood thinners in  patients. Moreover, other key industry players are increasing production capacities of renal equipment to meet the surge in requirement of these products owing to the coronavirus pandemic. For instance, Baxter has announced to hire 2,000 employees to meet the boost in demand of their infusion and renal care products.

LIST OF KEY COMPANIES PROFILED:

• Fresenius Medical Care AG & Co. KGaA  


• DaVita Healthcare Partners, Inc.


• B. Braun Melsungen AG


• Baxter International, Inc.


• Becton, Dickinson and Company


• Diaverum Healthcare Partners


• Medtronic


• Asahi Kasei Corporation


• Nipro Corporation

KEY INDUSTRY DEVELOPMENTS:

• June 2021 – Baxter International Inc., launched the Sharesource Analytics 1.0, the next generation digital health solution for home-based peritoneal dialysis (PD) patients. This digital solution is a clinical management resource within the Sharesource remote patient monitoring that provides healthcare professionals all the comprehensive data from their home dialysis patient’s treatment.


• May 2021 – DaVita Inc., expanded its home kidney care program by including the HomeChoice Claria automated peritoneal dialysis (APD) system from Baxter International Inc. This new technology enhanced the company’s home dialysis program and is an important step to promote dialysis at home.


• May 2021 – Fresenius Medical Care AG & Co. KGa introduced cloud based technology i.e. Kinexus therapy management platform in the market. This system supports management of peritoneal dialysis on the Liberty Select cycler and was designed to improve workflows, productivity and patient outcomes.


• March 2021 – Fresenius Medical Care AG & Co. KGaA extended its agreement with DaVita Inc., in order to provide NxStage home hemodialysis machines and related technologies to the large patient population in the U.S.

REPORT COVERAGE

An Infographic Representation of Dialysis Market

View Full Infographic

To get information on various segments, share your queries with us

The dialysis market research report offers qualitative and quantitative insights on the products and services and the detailed analysis of market size & growth rate for all possible segments in the market. Along with this, the report provides an elaborative analysis of market dynamics, emerging trends, and competitive landscape. Key insights offered in the report are the prevalence of CKD and ESRD for key countries, recent industry developments such as partnerships, merger & acquisitions, new product launch, reimbursement policies, regulatory scenario, and key market trends.

To gain extensive insights into the market, Request for Customization

Report Scope & Segmentation